HMO Infant Formula for Short-Term Memory via Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current infant formulas lack essential nutrients found in human breast milk, particularly human milk oligosaccharides (HMOs), which are crucial for the development and improvement of short-term memory and cognitive functions in infants and young children, especially preterm or fragile infants who require enhanced neuronal maturation.
Innovation Solution
A nutritional composition containing specific HMOs such as 2′-fucosyllactose (2FL) and lacto-N-neotetraose (LNnT) is administered to enhance short-term memory and declarative memory in infants and young children, promoting healthy brain development and cognitive functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If infant formulas are designed to mimic human breast milk composition, then cognitive development and short-term memory improvement are enhanced, but manufacturing complexity and cost increase due to the need to include specific HMOs
Solution Approach 1:
The patent extracts and isolates specific human milk oligosaccharides (2'-fucosyllactose and lacto-N-neotetraose) from the complex mixture of all HMOs found in human breast milk. By identifying and using only the two most critical HMOs for cognitive development, the formula achieves the desired cognitive benefits while significantly simplifying the manufacturing process and reducing costs compared to attempting to replicate the complete HMO profile.
Solution Approach 2:
The patent applies local quality by providing different HMO compositions tailored to specific developmental needs. Rather than using a uniform mixture of all HMOs, the formula specifically incorporates 2'-fucosyllactose and lacto-N-neotetraose in optimized proportions that target cognitive development and short-term memory formation, allowing precise nutritional intervention for brain development.
2Reliability
If complete HMO profile from human breast milk is replicated in formula, then all cognitive benefits are achieved, but production cost and difficulty increase significantly
Solution Approach 1:
The patent extracts and isolates specific human milk oligosaccharides (2'-fucosyllactose and lacto-N-neotetraose) from the complex mixture of all HMOs found in human breast milk. By identifying and using only the two most critical HMOs for cognitive development, the formula achieves the desired cognitive benefits while significantly simplifying the manufacturing process and reducing costs compared to attempting to replicate the complete HMO profile.
Solution Approach 2:
The patent employs cost-effective strategies by using commercially available 2'-fucosyllactose and lacto-N-neotetraose rather than attempting to synthesize or isolate the complete spectrum of HMOs. This approach uses affordable, readily obtainable ingredients that provide the essential cognitive benefits without requiring expensive complex manufacturing processes.
3Reliability
If HMOs are added to infant formula to improve short-term memory, then cognitive benefits are achieved, but the formula becomes more complex and deviates from standard formulations
Solution Approach 1:
The patent extracts and isolates specific human milk oligosaccharides (2'-fucosyllactose and lacto-N-neotetraose) from the complex mixture of all HMOs found in human breast milk. By identifying and using only the two most critical HMOs for cognitive development, the formula achieves the desired cognitive benefits while significantly simplifying the manufacturing process and reducing costs compared to attempting to replicate the complete HMO profile.
Solution Approach 2:
The patent applies local quality by providing different HMO compositions tailored to specific developmental needs. Rather than using a uniform mixture of all HMOs, the formula specifically incorporates 2'-fucosyllactose and lacto-N-neotetraose in optimized proportions that target cognitive development and short-term memory formation, allowing precise nutritional intervention for brain development.
Data Source
AI summary
The invention relates to a nutritional composition comprising a Human Milk Oligosaccharide (HMO) having an effect on the promoting, enhancement or improvement of the short term memory of the subjects in infants and/or young children. The composition can be an infant formula. The HMO may be 2FL, Di FL and/or LNT and or LNnT or combinations thereof.